본문으로 건너뛰기
← 뒤로

Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.

1/5 보강
Cardiovascular and interventional radiology 2026
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
18 patients who underwent subsequent liver transplantation or hepatectomy, increased surgical dissection time was documented in 6 (33%) patients secondary to presumed radiation-related adhesions.
I · Intervention 중재 / 시술
Yttrium-90-containing glass microsphere RS from 6/2017-9/2023 was performed
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] The incidence of severe GIAE following RS for HCC in the left hepatic lobe was low. Surgical adhesions after RS were common, but most did not increase surgical morbidity.

De La Garza-Ramos C, Silver C, Islam F, Gil-Lopez F, Lewandowski RJ, Toskich BB

📝 환자 설명용 한 줄

[PURPOSE] Describe the incidence and severity of gastrointestinal tract-related adverse events (GIAE) following radiation segmentectomy (RS) for hepatocellular carcinoma (HCC) in the left hepatic lobe

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 12
  • 추적기간 931 days

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA De La Garza-Ramos C, Silver C, et al. (2026). Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.. Cardiovascular and interventional radiology. https://doi.org/10.1007/s00270-026-04376-9
MLA De La Garza-Ramos C, et al.. "Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.." Cardiovascular and interventional radiology, 2026.
PMID 41735654

Abstract

[PURPOSE] Describe the incidence and severity of gastrointestinal tract-related adverse events (GIAE) following radiation segmentectomy (RS) for hepatocellular carcinoma (HCC) in the left hepatic lobe.

[MATERIALS AND METHODS] A single-center retrospective analysis of patients with solitary, treatment-naïve, HCC in the left hepatic lobe who underwent Yttrium-90-containing glass microsphere RS from 6/2017-9/2023 was performed. Clinical, endoscopic apparent, and surgical GIAE up to last available follow-up were graded per the Common Terminology Criteria for Adverse Events. Tumor-to-GI tract distance and treatment parameters were evaluated for associations with GIAE.

[RESULTS] Forty-six patients with a median tumor size of 2.4 cm (IQR 2.1, 3.6) and median follow-up of 931 days (IQR 527, 1412) met inclusion criteria. Median treatment dose was 533 Gy (IQR 456, 853). Grade 1 GIAE were documented on 14 (30%) patients, including nausea/emesis (n = 12) and gastritis/duodenitis (n = 2). Grade 2 GIAE were documented in 2 (4%) patients with either multifocal gastric and duodenal ulcers or gastric erosions per endoscopy performed at a median of 53 days post-RS without histologic evidence of Yttrium-90 microspheres or radiation injury. In the 18 patients who underwent subsequent liver transplantation or hepatectomy, increased surgical dissection time was documented in 6 (33%) patients secondary to presumed radiation-related adhesions. Two surgical cases (11%) had grade 4 AE, which included intraoperative hemorrhage and duodenal avulsion. No significant association was found between GIAE and tumor-to-GI tract distance, dosimetry, or treatment parameters.

[CONCLUSION] The incidence of severe GIAE following RS for HCC in the left hepatic lobe was low. Surgical adhesions after RS were common, but most did not increase surgical morbidity.